Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations. Chen YC, Tsai MJ, Lee MH, Kuo CY, et al. BMC Cancer 2021;21:495.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen YC, Tsai MJ, Lee MH, Kuo CY, et al. Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations. BMC Cancer 2021;21:495.
PMID: 33941115